Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Medicinas Complementárias
Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Brain Res ; 1757: 147304, 2021 04 15.
Artículo en Inglés | MEDLINE | ID: mdl-33524378

RESUMEN

The present study aimed to investigate the alterations of the GABAergic system in the laterodorsal nucleus (LDN) of the thalamus and the somatosensory cortex (SC) in an experimental model of absence seizure. The effects of pharmacological manipulation of both GABAA and GABAB receptor subunits in the LDN on the generation of spike-wave discharges (SWD) were evaluated. The experiments were carried out in four groups of both WAG/Rij and Wistar rats with 2 and 6 months of age. The expressions of various GABA receptor subunits were studied in the LDN and SC. Furthermore, recordings of unit activity from the LDN and electrocorticography were simultaneously monitored before, during, and after the application of GABAA and GABAB antagonists in the LDN. The generation of SWD in the older WAG/Rij rats was associated with significant alterations in the expression of GABAARα1, GABAARß3, and GABABR2 subunits in the LDN as well as GABAARα1, GABAARß3, GABAARγ2, and GABABR2 subunits in the SC. Furthermore, the occurrence of SWD was associated with a significant reduction of gene expression of GABAARα1 and increase of GABAARß3 in the LDN as well as reduction of GABAARα1, GABAARß3, GABAARγ2, and GABABR2 in the SC. The microionthophoretic application of the GABAA antagonist bicuculline resulted in a significant increase in the population firing rate of LDN neurons as well as the mean number and duration of SWD. The application of the GABAB antagonist CGP35348 significantly increased the population firing rate of LDN neurons but decreased the mean number of SWD. Our data indicate the regulatory effect of the GABAergic system of the LDN and SC in absence seizures.


Asunto(s)
Epilepsia Tipo Ausencia/tratamiento farmacológico , Antagonistas del GABA/farmacología , Receptores de GABA-B/efectos de los fármacos , Corteza Somatosensorial/efectos de los fármacos , Tálamo/efectos de los fármacos , Animales , Bicuculina/farmacología , Modelos Animales de Enfermedad , Electroencefalografía/métodos , Epilepsia Tipo Ausencia/fisiopatología , Masculino , Modelos Genéticos , Vías Nerviosas/efectos de los fármacos , Ratas , Corteza Somatosensorial/fisiopatología , Tálamo/fisiopatología
2.
Nutr Neurosci ; 20(2): 127-134, 2017 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25138625

RESUMEN

OBJECTIVES: The potential use of garlic for prevention and treatment of different types of headaches has been suggested by several medieval literatures. Cortical spreading depression (CSD), a propagating wave of neuroglial depolarization, was established as a target for anti-migraine drugs. This study was designed to investigate the effect of garlic extract on CSD in adult rats. METHODS: CSD was induced by KCl microinjection in the somatosensory cortex. The effects of five different concentrations of garlic oil (1-500 µl/l) were tested on different characteristic features of CSD in necocortical slices. In in vivo experiments, the effects of garlic oil on electrophysiological and morphological changes induced by CSD were investigated. RESULTS: Garlic oil in a dose-dependent manner decreased the amplitude of CSD but not its duration and velocity in neocortical brain slices. Garlic oil at concentration of 500 µl/l reversibly reduced the amplitude of the field excitatory post-synaptic potentials and inhibited induction of long-term potentiation in the third layer of neocortical slices. In in vivo studies, systemic application of garlic oil (1 ml/l) for three consecutive days reduced the amplitude and repetition rate of CSD. Garlic oil also prevented of CSD-induced reactive astrocytosis in the neocortex. DISCUSSION: Garlic oil suppresses CSD, likely via inhibition of synaptic plasticity, and prevents its harmful effects on astrocyte. Further studies are required to identify the exact active ingredient(s) of garlic oil that inhibit CSD and may have the potential to use in treatment of CSD-related disorders.


Asunto(s)
Compuestos Alílicos/farmacología , Depresión de Propagación Cortical/efectos de los fármacos , Ajo/química , Neocórtex/efectos de los fármacos , Neuronas/efectos de los fármacos , Extractos Vegetales/farmacología , Corteza Somatosensorial/efectos de los fármacos , Sulfuros/farmacología , Compuestos Alílicos/administración & dosificación , Analgésicos no Narcóticos/administración & dosificación , Analgésicos no Narcóticos/farmacología , Animales , Astrocitos/citología , Astrocitos/efectos de los fármacos , Astrocitos/patología , Astrocitos/fisiología , Tamaño de la Célula/efectos de los fármacos , Etnofarmacología , Gliosis/patología , Gliosis/prevención & control , Técnicas In Vitro , Inyecciones Intraperitoneales , Medicina Tradicional , Neocórtex/citología , Neocórtex/patología , Neocórtex/fisiología , Plasticidad Neuronal/efectos de los fármacos , Neuronas/citología , Neuronas/patología , Neuronas/fisiología , Concentración Osmolar , Extractos Vegetales/administración & dosificación , Raíces de Plantas/química , Ratas , Corteza Somatosensorial/citología , Corteza Somatosensorial/patología , Corteza Somatosensorial/fisiología , Sulfuros/administración & dosificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA